secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-05-04T23:59:59+00:00
Accession:  0001193125-26-204310
Event type: regulatory
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health cures Nasdaq publicly held shares deficiency via warrant exercises after reverse split
--------------------------------------------------------------------------------

- Received Nasdaq notice on May 1, 2026 for non-compliance with minimum 500,000 publicly held shares after 1-for-35 reverse split on April 30.
- Post-split publicly held shares were ~401,226, below the 500,000 requirement.
- On May 4, 2026, warrant exercises increased publicly held shares to 513,939.
- Company now has 513,974 total shares outstanding; awaiting Nasdaq formal confirmation of compliance.
- Reverse split had also triggered continued non-compliance with bid price rule until cure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526204310/0001193125-26-204310-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526204310/d941132d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-204310

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer